WO2023073513 - PHARMACEUTICAL COMPOSITION CONTAINING COMBINATION OF MELOXICAM AND RIZATRIPTAN AND PROCESS OF PREPARATION THEREOF
National phase entry is expected:
Publication Number
WO/2023/073513
Publication Date
04.05.2023
International Application No.
PCT/IB2022/060097
International Filing Date
20.10.2022
Title **
[English]
PHARMACEUTICAL COMPOSITION CONTAINING COMBINATION OF MELOXICAM AND RIZATRIPTAN AND PROCESS OF PREPARATION THEREOF
[French]
COMPOSITION PHARMACEUTIQUE CONTENANT UNE COMBINAISON DE MÉLOXICAM ET DE RIZATRIPTAN ET SON PROCÉDÉ DE PRÉPARATION
Applicants **
ALEMBIC PHARMACEUTICALS LIMITED
Alembic Research Center, Alembic Road
Vadodara 390 003, IN
Inventors
SYED AKHTAR, Syed Sabir
Alembic Pharmaceuticals Limited.
Lab Suites 111-112 & 113-114 on Ground Floor
Lab Suites 123 & 124 on First Floor
Block –1, Building 450
MN Park, Genome Valley, Shameerpet Turkapally (V), Medchal District
Hyderabad 500 078, IN
SAHOO, Barada Prasanna
Alembic Pharmaceuticals Limited.
Lab Suites 111-112 & 113-114 on Ground Floor
Lab Suites 123 & 124 on First Floor
Block –1, Building 450
MN Park, Genome Valley, Shameerpet Turkapally (V), Medchal District
Hyderabad 500 078, IN
DABRE, Rahul Sudhakar
Alembic Pharmaceuticals Limited.
Lab Suites 111-112 & 113-114 on Ground Floor
Lab Suites 123 & 124 on First Floor
Block –1, Building 450
MN Park, Genome Valley, Shameerpet Turkapally (V), Medchal District
Hyderabad 500 078, IN
Priority Data
202121048836
26.10.2021
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 964 | |
| EPO | Filing, Examination | 6427 | |
| Japan | Filing | 593 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 11269 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present subject matter relates to a solid oral pharmaceutical composition comprising combination of meloxicam and rizatriptan or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient. The present subject matter also relates to a fixed dose pharmaceutical composition comprising meloxicam and rizatriptan or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient. Furthermore, it also relates to methods for manufacturing such compositions and use thereof.[French]
La présente invention concerne une composition pharmaceutique orale solide comprenant une combinaison de méloxicam et de rizatriptan ou un sel pharmaceutiquement acceptable associé et au moins un excipient pharmaceutiquement acceptable. La présente invention concerne également une composition pharmaceutique à dose fixe comprenant du méloxicam et du rizatriptan ou un sel pharmaceutiquement acceptable associé et au moins un excipient pharmaceutiquement acceptable. En outre, l'invention concerne également des méthodes de fabrication de telles compositions et leur utilisation.